Correlation Between Intracellular and Journey Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Intracellular and Journey Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Intracellular and Journey Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Intracellular Th and Journey Medical Corp, you can compare the effects of market volatilities on Intracellular and Journey Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Intracellular with a short position of Journey Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Intracellular and Journey Medical.

Diversification Opportunities for Intracellular and Journey Medical

-0.52
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Intracellular and Journey is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Intracellular Th and Journey Medical Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Journey Medical Corp and Intracellular is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Intracellular Th are associated (or correlated) with Journey Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Journey Medical Corp has no effect on the direction of Intracellular i.e., Intracellular and Journey Medical go up and down completely randomly.

Pair Corralation between Intracellular and Journey Medical

Given the investment horizon of 90 days Intracellular is expected to generate 1.53 times less return on investment than Journey Medical. But when comparing it to its historical volatility, Intracellular Th is 2.18 times less risky than Journey Medical. It trades about 0.08 of its potential returns per unit of risk. Journey Medical Corp is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  212.00  in Journey Medical Corp on November 9, 2024 and sell it today you would earn a total of  288.00  from holding Journey Medical Corp or generate 135.85% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Intracellular Th  vs.  Journey Medical Corp

 Performance 
       Timeline  
Intracellular Th 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Intracellular Th are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite fairly uncertain fundamental indicators, Intracellular demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Journey Medical Corp 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Journey Medical Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest conflicting performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Intracellular and Journey Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Intracellular and Journey Medical

The main advantage of trading using opposite Intracellular and Journey Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Intracellular position performs unexpectedly, Journey Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Journey Medical will offset losses from the drop in Journey Medical's long position.
The idea behind Intracellular Th and Journey Medical Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes